RECRUITING

Automated Reinforcement Management Systems, Phase II

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The Automated Reinforcement Management Systems Phase II (ARMS II) study is a phase II trial is a randomized controlled, non-medicated assisted trial to determine the effectiveness of Contingency Management (CM) treatment for reducing alcohol drinking among adults who want to quit or reduce their alcohol consumption.

Official Title

Automated Reinforcement Management Systems, Phase II

Quick Facts

Study Start:2024-06-07
Study Completion:2025-09-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06456905

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 70 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 18-70 years
  2. * Have consumed 3 or more drinks in once occasion 4 or more times in the previous 30 days 3
  3. * Have the ability to read and speak English
  4. * Have the ability to provide written informed consent
  5. * Have a breath alcohol value of 0.00 during informed consent
  6. * Owns a smartphone with an active service provider that is compatible with the study application.
  1. * Severe alcohol use disorder that our medical staff deems too risky for safe participation;
  2. * Significant risk of dangerous alcohol withdrawal, defined as history of seizure due to alcohol withdrawal in the last 12 months and/or expression of concern by the participant about dangerous withdrawal
  3. * Anyone aged 71 or older.
  4. * Anyone with a suicide attempt in the last 2 years.
  5. * Individuals who express concern regarding dangerous withdrawal or who exhibit dangerous withdrawal symptoms.
  6. * Individuals who do not test BrAC = 0.00 on the breathalyzer during the baseline visit.
  7. * Any other condition that investigators determine a medical or psychiatric condition that would compromise safe study participation.

Contacts and Locations

Study Contact

Abigail L Bowen, MS
CONTACT
(425) 736-1354
abigail.bowen@wsu.edu

Principal Investigator

Sterling M McPherson, PhD
PRINCIPAL_INVESTIGATOR
Washington State University

Study Locations (Sites)

Washington State University
Spokane, Washington, 99202
United States

Collaborators and Investigators

Sponsor: Washington State University

  • Sterling M McPherson, PhD, PRINCIPAL_INVESTIGATOR, Washington State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-06-07
Study Completion Date2025-09-01

Study Record Updates

Study Start Date2024-06-07
Study Completion Date2025-09-01

Terms related to this study

Keywords Provided by Researchers

  • alcohol consumption
  • contingency management
  • alcohol dependency
  • positive reinforcement
  • remote treatment
  • non-medicated assisted treatment
  • alcohol studies

Additional Relevant MeSH Terms

  • Alcohol Use Disorder